semaglutide cardiovascular indication oral 2025 news Advance Release Article: A Cardiovascular Indication for Oral Semaglutide (Rybelsus) 🔗 Link in bio Medicare to Cover Wegovy for

Clinical Trial Results for Orforglipron Eli Lillys Phase 3 ACHIEVE trial program has produced encouraging numbers

While these medications commonly cause gastrointestinal side effects such as nausea and constipation, back pain is not listed as a characteristic adverse effect in FDA prescribing information

In the subgroup at high cardiovascular risk, effect estimates were similar (HR 0.80, 95% CI 0.71 to 0.91)

The findings of this study indicate that the treatment of vitamin B12 deficiency can serve as a preventive measure against dementia and strokes.

PLoS One 8 (5), e63784

Verdict: Better than nothing, but youre hoping your body does the work